Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe

This study has been completed.
PENTA Foundation
Information provided by (Responsible Party):
Bristol-Myers Squibb Identifier:
First received: July 6, 2011
Last updated: December 22, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)